1
|
Camarca A, Varriale A, Capo A, Pennacchio A, Calabrese A, Giannattasio C, Murillo Almuzara C, D’Auria S, Staiano M. Emergent Biosensing Technologies Based on Fluorescence Spectroscopy and Surface Plasmon Resonance. SENSORS (BASEL, SWITZERLAND) 2021; 21:906. [PMID: 33572812 PMCID: PMC7866296 DOI: 10.3390/s21030906] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/24/2020] [Revised: 01/22/2021] [Accepted: 01/25/2021] [Indexed: 12/23/2022]
Abstract
The purpose of this work is to provide an exhaustive overview of the emerging biosensor technologies for the detection of analytes of interest for food, environment, security, and health. Over the years, biosensors have acquired increasing importance in a wide range of applications due to synergistic studies of various scientific disciplines, determining their great commercial potential and revealing how nanotechnology and biotechnology can be strictly connected. In the present scenario, biosensors have increased their detection limit and sensitivity unthinkable until a few years ago. The most widely used biosensors are optical-based devices such as surface plasmon resonance (SPR)-based biosensors and fluorescence-based biosensors. Here, we will review them by highlighting how the progress in their design and development could impact our daily life.
Collapse
Affiliation(s)
- Alessandra Camarca
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Antonio Varriale
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
- URT-ISA at Department of Biology, University of Naples Federico II, 80126 Napoli, Italy
| | - Alessandro Capo
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Angela Pennacchio
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Alessia Calabrese
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Cristina Giannattasio
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Carlos Murillo Almuzara
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Sabato D’Auria
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| | - Maria Staiano
- Institute of Food Science, CNR Italy, 83100 Avellino, Italy; (A.C.); (A.V.); (A.C.); (A.P.); (A.C.); (C.G.); (C.M.A.); (M.S.)
| |
Collapse
|
2
|
Flynn C, Ignaszak A. Lyme Disease Biosensors: A Potential Solution to a Diagnostic Dilemma. BIOSENSORS 2020; 10:E137. [PMID: 32998254 PMCID: PMC7601730 DOI: 10.3390/bios10100137] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Revised: 09/24/2020] [Accepted: 09/27/2020] [Indexed: 02/06/2023]
Abstract
Over the past four decades, Lyme disease has remained a virulent and pervasive illness, persisting throughout North America and many other regions of the world. Recent increases in illness in many countries has sparked a renewed interest in improved Lyme diagnostics. While current standards of diagnosis are acceptable for the late stages of the disease, it remains difficult to accurately diagnose early forms of the illness. In addition, current diagnostic methods tend to be relatively expensive and require a large degree of laboratory-based analysis. Biosensors represent the fusion of biological materials with chemical techniques to provide simple, inexpensive alternatives to traditional diagnostic methods. Lyme disease biosensors have the potential to better diagnose early stages of the illness and provide possible patients with an inexpensive, commercially available test. This review examines the current state of Lyme disease biosensing, with a focus on previous biosensor development and essential future considerations.
Collapse
Affiliation(s)
- Connor Flynn
- Department of Chemistry, University of New Brunswick, Fredericton, NB E3B 5A3, Canada;
| | | |
Collapse
|
3
|
Alasel M, Keusgen M. Promising alternatives for one-tier testing of Lyme borreliosis. Clin Chim Acta 2018; 479:148-154. [PMID: 29366833 DOI: 10.1016/j.cca.2018.01.030] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Revised: 01/15/2018] [Accepted: 01/19/2018] [Indexed: 11/16/2022]
Abstract
A main focus of human health studies is the early detection of infectious diseases to enable more rapid treatment and prevent disease transmission. Diagnosis of Lyme borreliosis has been always challenging because of the lack of specific, but simple assay formats. Two-tiered testing has been recommended by US Centers for Disease Control and Prevention to provide more specific results for diagnosis of Lyme disease. However, such a technique is time consuming and is not well suited for early stage detection. Therefore, many tests were proposed as alternatives to overcome these drawbacks. Simple assays, which are mainly performed in one-tier manner, could be conducted with better performance than the two-tiered testing. Proposed assays utilize both newly identified antigens and new platforms to improve detection performance. These assays can be classified into those based on employing a single antigen and assays based on using multiple antigens. In addition to assays to this type of assays, immunoassays on borreliosis-related biomarkers are available. We report here the most recent assays developed over the last 10 years, for detection of Lyme borreliosis in body fluids.
Collapse
Affiliation(s)
- Mohammed Alasel
- Institute of Pharmaceutical Chemistry, Philipps-Universität, Marbacher Weg 6-10, 35032 Marburg, Germany.
| | - Michael Keusgen
- Institute of Pharmaceutical Chemistry, Philipps-Universität, Marbacher Weg 6-10, 35032 Marburg, Germany
| |
Collapse
|
4
|
Abstract
The design and application of sensors for monitoring biomolecules in clinical samples is a common goal of the sensing research community. Surface plasmon resonance (SPR) and other plasmonic techniques such as localized surface plasmon resonance (LSPR) and imaging SPR are reaching a maturity level sufficient for their application in monitoring biomolecules in clinical samples. In recent years, the first examples for monitoring antibodies, proteins, enzymes, drugs, small molecules, peptides, and nucleic acids in biofluids collected from patients afflicted with a series of medical conditions (Alzheimer's, hepatitis, diabetes, leukemia, and cancers such as prostate and breast cancers, among others) demonstrate the progress of SPR sensing in clinical chemistry. This Perspective reviews the current status of the field, showcasing a series of early successes in the application of SPR for clinical analysis and detailing a series of considerations regarding sensing schemes, exposing issues with analysis in biofluids, and comparing SPR with ELISA, while providing an outlook of the challenges currently associated with plasmonic materials, instrumentation, microfluidics, bioreceptor selection, selection of a clinical market, and validation of a clinical assay for applying SPR sensors to clinical samples. Research opportunities are proposed to further advance the field and transition SPR biosensors from research proof-of-concept stage to actual clinical applications.
Collapse
Affiliation(s)
- Jean-Francois Masson
- Département
de chimie, Université de Montréal, C.P. 6128 Succ. Centre-Ville, Montreal, Quebec H3C 3J7, Canada
- Centre
for self-assembled chemical structures (CSACS), McGill University, 801
Sherbrooke Street West, Montreal, Quebec H3A 2K6, Canada
| |
Collapse
|
5
|
Wong WR, Krupin O, Sekaran SD, Mahamd Adikan FR, Berini P. Serological diagnosis of dengue infection in blood plasma using long-range surface plasmon waveguides. Anal Chem 2014; 86:1735-43. [PMID: 24410440 DOI: 10.1021/ac403539k] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We present a compact, cost-effective, label-free, real-time biosensor based on long-range surface plasmon polariton (LRSPP) gold (Au) waveguides for the detection of dengue-specific immunoglobulin M (IgM) antibody, and we demonstrate detection in actual patient blood plasma samples. Two surface functionalization approaches are proposed and demonstrated: a dengue virus serotype 2 (DENV-2) functionalized surface to capture dengue-specific IgM antibody in blood plasma and the reverse, a blood plasma functionalized surface to capture DENV-2. The results obtained via these two surface functionalization approaches are comparable to, or of greater quality, than those collected by conventional IgM antibody capture enzyme linked immunosorbent assay (MAC-ELISA). Our second functionalization approach was found to minimize nonspecific binding, thus improving the sensitivity and accuracy of the test. We also demonstrate reuse of the biosensors by regenerating the sensing surface down to the virus (or antibody) level or down to the bare Au.
Collapse
Affiliation(s)
- Wei Ru Wong
- Photonics Research Group, Department of Electrical Engineering, Faculty of Engineering, University of Malaya , 50603 Kuala Lumpur, Malaysia
| | | | | | | | | |
Collapse
|
6
|
Scholten A, Menges B, Juebner M, Rothschild MA, Bender K. A mixed alkanethiol based immunosensor for surface plasmon field-enhanced fluorescence spectroscopy in serum. Analyst 2013; 138:1705-12. [DOI: 10.1039/c3an35657d] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
7
|
Diltemiz SE, Ersöz A, Hür D, Keçili R, Say R. 4-Aminophenyl boronic acid modified gold platforms for influenza diagnosis. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2012; 33:824-30. [PMID: 25427493 DOI: 10.1016/j.msec.2012.11.007] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2012] [Revised: 07/31/2012] [Accepted: 11/05/2012] [Indexed: 11/19/2022]
Abstract
As a potential pandemic threat to human health, there has been an urgent need for rapid, sensitive, simpler and less expensive detection method for the highly pathogenic influenza A virus. For this purpose, Quartz Crystal Microbalance (QCM) and Surface Plasmon Resonance (SPR) sensors have been developed for the recognition of hemagglutinin (HA) which is a major protein of influenza A virus. 4-Aminophenyl boronic acid (4-APBA) has been synthesized and used as a new ligand for binding of sialic acid (SA) via boronic acid-sugar interaction. SA has an important role in binding of HA. QCM and SPR sensor surfaces have been modified with thiol groups and then 4-APBA and SA have been immobilized on sensor surfaces, respectively. Sensor surfaces have been screened with AFM and used for the determination of HA from aqueous solution. The selective recognition of the QCM and SPR sensors toward Concanavalin A has been reported in this work. Also, the binding capacity and detection limits of QCM and SPR sensors have been calculated and detection limits were found to be 4.7 × 10(-2) μM, (0.26 μg ml(-1)) and 1.28 × 10(-1) μM, (0.72 μg ml(-1)) in the 95% confidence interval, respectively.
Collapse
Affiliation(s)
| | - Arzu Ersöz
- Department of Chemistry, Anadolu University, Eskişehir, Turkey
| | - Deniz Hür
- Department of Chemistry, Anadolu University, Eskişehir, Turkey
| | - Rüstem Keçili
- Department of Chemistry, Anadolu University, Eskişehir, Turkey
| | - Ridvan Say
- Department of Chemistry, Anadolu University, Eskişehir, Turkey
| |
Collapse
|
8
|
Köhler K, Seitz H. Validation processes of protein biomarkers in serum--a cross platform comparison. SENSORS (BASEL, SWITZERLAND) 2012; 12:12710-28. [PMID: 23112739 PMCID: PMC3478866 DOI: 10.3390/s120912710] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/31/2012] [Revised: 09/06/2012] [Accepted: 09/10/2012] [Indexed: 12/14/2022]
Abstract
Due to insufficient biomarker validation and poor performances in diagnostic assays, the candidate biomarker verification process has to be improved. Multi-analyte immunoassays are the tool of choice for the identification and detailed validation of protein biomarkers in serum. The process of identification and validation of serum biomarkers, as well as their implementation in diagnostic routine requires an application of independent immunoassay platforms with the possibility of high-throughput. This review will focus on three main multi-analyte immunoassay platforms: planar microarrays, multiplex bead systems and, array-based surface plasmon resonance (SPR) chips. Recent developments of each platform will be discussed for application in clinical proteomics, principles, detection methods, and performance strength. The requirements for specific surface functionalization of assay platforms are continuously increasing. The reasons for this increase is the demand for highly sensitive assays, as well as the reduction of non-specific adsorption from complex samples, and with it high signal-to-noise-ratios. To achieve this, different support materials were adapted to the immobilized biomarker/ligand, allowing a high binding capacity and immobilization efficiency. In the case of immunoassays, the immobilized ligands are proteins, antibodies or peptides, which exhibit a diversity of chemical properties (acidic/alkaline; hydrophobic/hydrophilic; secondary or tertiary structure/linear). Consequently it is more challenging to develop immobilization strategies necessary to ensure a homogenous covered surface and reliable assay in comparison to DNA immobilization. New developments concerning material support for each platform are discussed especially with regard to increase the immobilization efficiency and reducing the non-specific adsorption from complex samples like serum and cell lysates.
Collapse
Affiliation(s)
- Katja Köhler
- Fraunhofer Institute for Biomedical Engineering IBMT, Branch Potsdam-Golm, Am Mühlenberg 13, 14476 Potsdam-Golm, Germany; E-Mail:
| | - Harald Seitz
- Fraunhofer Institute for Biomedical Engineering IBMT, Branch Potsdam-Golm, Am Mühlenberg 13, 14476 Potsdam-Golm, Germany; E-Mail:
| |
Collapse
|
9
|
Real-time monitoring of biomolecular interactions in blood plasma using a surface plasmon resonance biosensor. Anal Bioanal Chem 2010; 398:1955-61. [DOI: 10.1007/s00216-010-4159-9] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2010] [Revised: 08/18/2010] [Accepted: 08/20/2010] [Indexed: 10/19/2022]
|
10
|
Rich RL, Myszka DG. Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'. J Mol Recognit 2010; 23:1-64. [PMID: 20017116 DOI: 10.1002/jmr.1004] [Citation(s) in RCA: 109] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Optical biosensor technology continues to be the method of choice for label-free, real-time interaction analysis. But when it comes to improving the quality of the biosensor literature, education should be fundamental. Of the 1413 articles published in 2008, less than 30% would pass the requirements for high-school chemistry. To teach by example, we spotlight 10 papers that illustrate how to implement the technology properly. Then we grade every paper published in 2008 on a scale from A to F and outline what features make a biosensor article fabulous, middling or abysmal. To help improve the quality of published data, we focus on a few experimental, analysis and presentation mistakes that are alarmingly common. With the literature as a guide, we want to ensure that no user is left behind.
Collapse
Affiliation(s)
- Rebecca L Rich
- Center for Biomolecular Interaction Analysis, University of Utah, Salt Lake City, UT 84132, USA
| | | |
Collapse
|
11
|
A synthetic membrane protein in tethered lipid bilayers for immunosensing in whole blood. J Struct Biol 2009; 168:177-82. [DOI: 10.1016/j.jsb.2009.03.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2008] [Revised: 03/20/2009] [Accepted: 03/22/2009] [Indexed: 01/09/2023]
|
12
|
Antibody-based sensors: principles, problems and potential for detection of pathogens and associated toxins. SENSORS 2009; 9:4407-45. [PMID: 22408533 PMCID: PMC3291918 DOI: 10.3390/s90604407] [Citation(s) in RCA: 190] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/07/2009] [Revised: 05/26/2009] [Accepted: 05/26/2009] [Indexed: 01/30/2023]
Abstract
Antibody-based sensors permit the rapid and sensitive analysis of a range of pathogens and associated toxins. A critical assessment of the implementation of such formats is provided, with reference to their principles, problems and potential for 'on-site' analysis. Particular emphasis is placed on the detection of foodborne bacterial pathogens, such as Escherichia coli and Listeria monocytogenes, and additional examples relating to the monitoring of fungal pathogens, viruses, mycotoxins, marine toxins and parasites are also provided.
Collapse
|
13
|
Richens JL, Urbanowicz RA, Lunt EAM, Metcalf R, Corne J, Fairclough L, O'Shea P. Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease. Respir Res 2009; 10:29. [PMID: 19386108 PMCID: PMC2678087 DOI: 10.1186/1465-9921-10-29] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2009] [Accepted: 04/22/2009] [Indexed: 01/10/2023] Open
Abstract
Chronic obstructive pulmonary disease (COPD) is a treatable and preventable disease state, characterised by progressive airflow limitation that is not fully reversible. Although COPD is primarily a disease of the lungs there is now an appreciation that many of the manifestations of disease are outside the lung, leading to the notion that COPD is a systemic disease. Currently, diagnosis of COPD relies on largely descriptive measures to enable classification, such as symptoms and lung function. Here the limitations of existing diagnostic strategies of COPD are discussed and systems biology approaches to diagnosis that build upon current molecular knowledge of the disease are described. These approaches rely on new 'label-free' sensing technologies, such as high-throughput surface plasmon resonance (SPR), that we also describe.
Collapse
Affiliation(s)
- Joanna L Richens
- Cell Biophysics Group, School of Biology, The University of Nottingham, NG7 2RD, UK.
| | | | | | | | | | | | | |
Collapse
|
14
|
Uzun L, Say R, Unal S, Denizli A. Production of surface plasmon resonance based assay kit for hepatitis diagnosis. Biosens Bioelectron 2009; 24:2878-84. [PMID: 19303282 DOI: 10.1016/j.bios.2009.02.021] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2009] [Accepted: 02/18/2009] [Indexed: 02/06/2023]
Abstract
Hepatitis B surface antibody (HBsAb) imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-L-tyrosine methyl ester) (PHEMAT) film on the surface plasmon resonance (SPR) sensor chip was prepared for diagnosis of HBsAb in human serum. Gold SPR chip surface was modified with allyl mercaptane and, then, HBsAb-imprinted PHEMAT film was formed on the chip surface. Surface characterization of the non-modified, allyl mercaptane modified and HBsAb-imprinted PHEMAT SPR chips were investigated with contact angle, atomic force microscopy (AFM). Kinetic studies were performed using HBsAb positive human serum. In order to determine the kinetic and binding constants, Scatchard, Langmuir, Freundlich and Langmuir-Freundlich models were applied to experimental data. Scatchard curve shows that HBsAb imprinted SPR chip has some surface heterogeneity, SPR chip obeyed the Langmuir adsorption model. The maximum detection limit was 208.2 mIU/mL. K(A) and K(D) values are 0.015 mIU/mL and 66.0 mL/mIU, respectively. Control experiments of the SPR chip were performed using non-immunized, HBsAb negative serum. The control experiment results show that SPR chip does not give any noticeable response to HBsAb negative serum.
Collapse
Affiliation(s)
- Lokman Uzun
- Department of Chemistry, Biochemistry Division, Hacettepe University, Beytepe, 06532 Ankara, Turkey
| | | | | | | |
Collapse
|
15
|
Taitt CR, Shriver-Lake LC, Ngundi MM, Ligler FS. Array Biosensor for Toxin Detection: Continued Advances. SENSORS 2008; 8:8361-8377. [PMID: 27873991 PMCID: PMC3791022 DOI: 10.3390/s8128361] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/31/2008] [Revised: 11/26/2008] [Accepted: 12/09/2008] [Indexed: 11/17/2022]
Abstract
The following review focuses on progress made in the last five years with the NRL Array Biosensor, a portable instrument for rapid and simultaneous detection of multiple targets. Since 2003, the Array Biosensor has been automated and miniaturized for operation at the point-of-use. The Array Biosensor has also been used to demonstrate (1) quantitative immunoassays against an expanded number of toxins and toxin indicators in food and clinical fluids, and (2) the efficacy of semi-selective molecules as alternative recognition moieties. Blind trials, with unknown samples in a variety of matrices, have demonstrated the versatility, sensitivity, and reliability of the automated system.
Collapse
Affiliation(s)
- Chris Rowe Taitt
- Center for Bio/Molecular Science & Engineering, Naval Research Laboratory, Code 6900, Washington, DC 20375-5348, USA.
| | - Lisa C Shriver-Lake
- Center for Bio/Molecular Science & Engineering, Naval Research Laboratory, Code 6900, Washington, DC 20375-5348, USA.
| | - Miriam M Ngundi
- Food and Drug Administration, N29 RM418 HFM-434, 8800 Rockville Pike, Bethesda, MD 20892, USA.
| | - Frances S Ligler
- Center for Bio/Molecular Science & Engineering, Naval Research Laboratory, Code 6900, Washington, DC 20375-5348, USA.
| |
Collapse
|